Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
International Journal of Clinical Oncology|July 7, 2025
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective studyFumiya Yoneyama, Naoki Fujita, Yohei Kawashima, et al.The Prostate|May 26, 2026
Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective StudyHimawari Asanuma, Naoki Fujita, Shumon Kato, et al.Neuro-Oncology|March 11, 2024
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade gliomaDaniel C Moreira, Ibrahim Qaddoumi, Susan Spiller, et al.Scientific Reports|March 29, 2025
Multicenter, international, retrospective study of prognostic factors for Ra223Takuya Oishi, Hao-Lun Luo, Yoshiomi Hatayama, et al.Renal Failure|June 3, 2025
The long-term impact of mild COVID-19 on cardiovascular disease and mortality in patients on hemodialysis: a post-Omicron era retrospective observational studyAkiko Okamoto, Teppei Okamoto, Takaki Ichiyama, et al.Biorxiv : the Preprint Server for Biology|May 18, 2026
<i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric MedulloblastomaRyuma Tanaka, Banlanjo Umaru, Matthew Sobo, et al.Cancer Epidemiology|June 5, 2026
Racial disparities in pediatric cancer hospitalizations in the United StatesTugce Kutuk, Raj Singh, Vedat Yildiz, et al.Neuro-Oncology|February 7, 2019
Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysisJason C H Chiang, Julie H Harreld, Ryuma Tanaka, et al.Acta Neuropathologica|August 11, 2025
Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysisMargit K Mikkelsen, Xiaoyu Li, Kaiwen Yu, et al.Cancer Discovery|October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD ConsortiumAnirban Das, Nicholas R Fernandez, Adrian Levine, et al.Pageof 4